• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Familial hypercholesterolaemia

Familial hypercholesterolaemia

Status:	In progress
Expected Date of Issue:	August 2013
Topic area: Endocrine, nutritional and metabolic

Project team | Project history | Key documents

 

NICE project team

Associate Director:	Nick Baillie
Consultant Clinical Adviser:	Tim Stokes
Programme Manager:	Rachel Neary
Lead Technical Analyst:	Nicola Greenway
Project Manager:	Esther Clifford
Co-ordinator:	Lee Berry

Top

 

Project history

Date Update 26 April 2013 Topic expert group meet for final time to discuss the consultation response 28 March 2013 Consultation on the draft quality standard ends 28 February 2013 Consultation on the draft quality standard begins 18 December 2012 Topic expert group meet to draft the quality statements and measures 17 Sept 2012 Topic expert group met for the first time to consider the scope of the topic as well as relevant evidence sources for development of the standard

Top

 

Key documents

Familial hypercholesterolaemia: TEG 2 minutes 28 February 2013 Familial hypercholesterolaemia: quality standard consultation 28 February 2013 Familial hypercholesterolaemia: equality analyses 14 December 2012 Familial hypercholesterolaemia: Topic Expert Group members 12 December 2012 Familial hypercholesterolaemia: scope 17 October 2012 Familial hypercholesterolaemia: TEG 1 minutes 17 October 2012 Familial hypercholesterolaemia: list of registered stakeholders 28 February 2013 Stakeholder registration form 12 December 2012

Email enquiries

If you have any queries please email qualitystandards@nice.org.uk

Top

This page was last updated: 28 February 2013